Transcriptional activation of the bcl-2 apoptosis suppressor gene by the paired box transcription factor PAX8

Anticancer Research

Volumn 17, Issue 5 A, 1997, Pages 3211-3215

  Hewitt, Stephen M ^a,b   Hamada, Shinshichi ^a   Monarres, Angela ^a   Kottical, Lazar V ^a   Saunders, Grady F ^a   Mcdonnell, Timothy J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; bcl 2 ; Pax8; Promoter; Transcription factor

Indexed keywords

PROTEIN BCL 2; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; ELECTROPHORETIC MOBILITY; HUMAN; HUMAN CELL; KIDNEY TUBULE EPITHELIUM; PRIORITY JOURNAL; PROMOTER REGION; SUPPRESSOR GENE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

APOPTOSIS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; NUCLEAR PROTEINS; PAIRED BOX TRANSCRIPTION FACTORS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-BCL-2; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC;

EID: 0030778438     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Chandler, D, El-Naggar, AK, Brisbay, S, Redline, RW, and McDonnell. TJ: Apoptosis and expression of the bc1-2 proto-oncogene in the fetal and adult human kidney:evidence for the contribution of bc1-2 expression to renal carcinogenesis. Human Pathol 25: 789-796, 1994.
2. Lu, Q-L, Poulsom, R, Wong, L, and Hanby, AM: BCL-2 expression in adult and embryonic non-haematopoietic tissues. J Path. 169: 431-437, 1993.
3. LeBrun, DP, Warnke, RA, and Cleary, ML: Expression of bc1-2 in fetal tissues suggests a role in morphogenesis. Amer. J. Path. 142: 743-753, 1993.
4. Allsopp TE, Wyatt S, Paterson HF, and Davies AM: The Proto-Oncogene bc1-2 Can Selectively Rescue Neurotrophic Factor-Dependent Neurons from Apoptosis. Cell 73: 295307, 1993.
5. Garcia I, Martinou I, Tsujimoto Y, and Martinou JC: Prevention of Programmed Cell Death of Sympathetic Neurons by the bcl-2 Proto-Oncogene. Science 258: 302-304, 1992.
6. Paraf F, Gogusev J, Chretien Y and Droz D: Expression of bc1-2 oncoprotein in renal cell tumours. J Path 177: 247-252, 1995.
7. Veis, DJ, Sorenson, CM, Shutter, JR and Korsmeyer, SJ: Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75: 229-240, 1993.
8. Nakayama, K, Nakayama, KI, Negishi, I, Kuida, K, Sawa, H. and Loh, DY: Targeted disruption of Bcl-2αß in mice. Proc. Natl. Acad. Sci. USA 91: 3700-3704, 1994.
9. Nagata, M, Nakauchi, H, Nakayama, K, Nakayama, K, Loh, D, Watanabe, T: Apoptosis during an early stage of nephrogenesis induces renal hypoplasia in bcl-2-deficient mice. Am J Pathol 148: 1601-11, 1996
10. Soronson, CM, Padanilam BJ, Hammerman MR: Abnormal postpartum renal development and cystogenesis in the bc1-2 (-/-) mouse. Am J Physiol 271: F184-93, 1996.
11. Seto, A, Jaeger, U, Hockett, RD, Graninger, W, Bennett, S, Goldman, P and Korsmeyer, SJ: Alternative promoters and exons, somatic mutation and dergulation of the Bc1-2-Ig fusion gene in lymphoma. EMBO J. 7: 123-131, 1988.
12. Hewitt SM, Hamada S, McDonnell TJ, Rauscher FJ III, and Saunders GF: Regulation of the Proto-oncogenes bc1-2 and c-myc by the Wilms' Tumor Suppressor Gene WTl. Cancer Research 55: 5386-5389, 1995.
13. Haldar, S, Negrini, M, Monne, M, Sabbioni, S, and Croce, CM: Down-Regulation of bcl-2 by p53 in Breast Cancer Cells. Cancer Research 54: 2095-2097, 1994.
14. Miyashita, T, Harigai, M, Hamada, M, and Reed, JC: Identification of a p53-dependent Negative Response Element in the bc1-2 Gene. Cancer Research 54: 3131-3135, 1994.
15. Chalepakis G, Goulding M, Read A, Strachan T, and Gruss P: Molecular basis of splotch and Waardenburg Pax-3 mutations. Proc. Natl. Acad. Sci. USA 91: 3685-3689, 1994.
16. Czerny T, Schaffner G and Busslinger M: DNA sequence recognition by Pax proteins: bipartite structure of the paired domain and its binding site. Genes Dev. 7: 2048-2061, 1993.
17. Fickenscher HR, Chalepakis G and Gruss P: Murine Pax-2 protein is a sequence specific transactivator with expression in the genital system. DNA and Cell Biol. 12: 381-391, 1993.
18. Gruss P and Walther C: Pax in Development. Cell 69: 719-722, 1992.
19. Noll M: Evolution and role of Pax genes. Curr. Opin. Genet. 4: 595-605, 1993.
20. Plachov D, Chowdhury, K, Walther, C, Simon, D, Guenet, J-L, and Gruss, P: Pax8, a murine paired box gene expressed in the developing excretory system and thyroid gland. Development 110: 643-651, 1990.
21. Poleev A, Fickenscher, H, Munlos, S, Winterpacht, A, Zabel, B, Fidler, A, Gruss, P, and Plachov, P: PAX8, a human paired box gene: isolation and expression in developing thyroid, kidney and Wilms' tumors. Development 116: 611-623, 1992.
22. Kozmik Z, Kurzbauer R, Dorfler P, and Busslinger M: Alteranative Splicing of Pax-8 Gene Transcripts Is Developmentally Regulated and Generates Isoforms with Different Transactivation Properties. Mol Cell Biol 13: 6024-6035, 1993.
23. Eccles MR, Wallis, LJ, Fidler, AE, Spurr, NK, Goodfellow, PJ, and Reeve, AE: Expression of the PAX2 Gene in Human Fetal Kidney and Wilms' Tumor. Cell Growth Differ 3: 279-289, 1992.
24. Dressler GR and Douglas EC: Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor. Proc Natl Acad Sci USA 89: 1179-1183, 1992.
25. Dressler G R, Wilkinson, JE, Rothenpieler, UW, Patterson, LT, Williams-Simons, L, and Westphal, H: Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities. Nature 362: 65-67, 1993.
26. Dressler GR, Deutsch U, Chowdhury K, Nornes HO and Gruss P: Pax2, a new murine paired-box-containing gene and its expression in the developing excretory system. Development 109: 787-795, 1990.
27. Adams B, Dorfler, P, Aguzzi, A, Kozmik, Z, Urbanek, P, Maurer-Fogy, and Busslinger M: Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis. (1992) Genes Dev 6: 1589-1607, 1992.
28. Poleev, A, Wendler, F, Fickenscher, H, Zannini, MS, Yaginuma, K, Abbott, C, and Plachov, D: Distinct functional properties of three human paired-box-protein, PAX8, isoforms generated by alternative splicing in thyroid, kidney and Wilms' tumor. Eur J Biochem 228: 899-911, 1995.
29. Zannini M, Francis-Lang H, Plachov D, and Di Lauro R: Pax-8, a Paired DomainContaining Protein, Binds to a Sequence Overlapping the Recognition Site of a Homeodomain and Activates Transcription from Two Thyroid-Specific Promoters. Mol. Cell Biol 12: 4230-4241, 1992.
30. Holst BD, Goomer RS, Wood IC, Edelman GM and Jones FS: Binding and Activation of the Promoter for the Neural Cell Adhesion Molecule by Pax-8 J Biol Chem 269: 22245-22252, 1994.
31. Merry DE, Veis DJ, Hickey WF and Korsmeyer SJ: bc1-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. Development 120:301-311, 1994.
32. Pilotti S, Collini P, Rilke F, Cattoretti G, Del Bo R, and Pierotti MA: BCL-2 Protein Expression in Carcinomas Originating from the Follicular Epithelium of the Thyroid Gland. J Pathol. 172: 337-342, 1994.
33. Maulbecker CC and Gruss P: The oncogenic potential of Pax genes. EMBO J 12: 2361-2367, 1993.